TWI350758B - Pharmaceutical composition for activating fas/fas ligand pathway - Google Patents
Pharmaceutical composition for activating fas/fas ligand pathwayInfo
- Publication number
- TWI350758B TWI350758B TW097114343A TW97114343A TWI350758B TW I350758 B TWI350758 B TW I350758B TW 097114343 A TW097114343 A TW 097114343A TW 97114343 A TW97114343 A TW 97114343A TW I350758 B TWI350758 B TW I350758B
- Authority
- TW
- Taiwan
- Prior art keywords
- fas
- pharmaceutical composition
- activating
- ligand pathway
- pathway
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW097114343A TWI350758B (en) | 2008-04-18 | 2008-04-18 | Pharmaceutical composition for activating fas/fas ligand pathway |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW097114343A TWI350758B (en) | 2008-04-18 | 2008-04-18 | Pharmaceutical composition for activating fas/fas ligand pathway |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200944221A TW200944221A (en) | 2009-11-01 |
TWI350758B true TWI350758B (en) | 2011-10-21 |
Family
ID=44869233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097114343A TWI350758B (en) | 2008-04-18 | 2008-04-18 | Pharmaceutical composition for activating fas/fas ligand pathway |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI350758B (en) |
-
2008
- 2008-04-18 TW TW097114343A patent/TWI350758B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW200944221A (en) | 2009-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUS1800007I1 (en) | Pharmaceutical composition | |
IL228817A0 (en) | Pharmaceutical composition | |
EP2133095A4 (en) | Pharmaceutical composition | |
EP2133094A4 (en) | Pharmaceutical composition | |
EP2191826A4 (en) | Pharmaceutical composition | |
ZA200905224B (en) | Pharmaceutical composition | |
EP2224805A4 (en) | Pharmaceutical composition | |
EP2224915A4 (en) | Pharmaceutical composition | |
ZA201102715B (en) | Solid pharmaceutical composition | |
IL208387A0 (en) | Pharmaceutical composition | |
HK1138774A1 (en) | Pharmaceutical composition | |
EP2224808A4 (en) | Pharmaceutical composition | |
ZA201100871B (en) | Solid pharmaceutical composition | |
EP2156832A4 (en) | Pharmaceutical composition | |
ZA201006224B (en) | Pharmaceutical composition | |
EP2327406A4 (en) | Stabilized pharmaceutical composition | |
EP2224806A4 (en) | Pharmaceutical composition | |
GB2464200B (en) | Pharmaceutical composition | |
IL205975A0 (en) | Pharmaceutical composition | |
GB0817969D0 (en) | Pharmaceutical composition | |
TWI350758B (en) | Pharmaceutical composition for activating fas/fas ligand pathway | |
IL205931A0 (en) | Pharmaceutical composition | |
GB0817974D0 (en) | Pharmaceutical composition | |
GB0817566D0 (en) | Pharmaceutical composition | |
GB0717036D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |